Lucinda Orsini
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Neurology top 5%
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 5
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 5
- Cancer Research top 10%
-
- Health Systems, Economic Evaluations, Quality of Life 10
-
- Lung Cancer Treatments and Mutations 8
- Lung Cancer Diagnosis and Treatment 3
-
- Statistical Methods in Clinical Trials 4
- Advanced Causal Inference Techniques 3
- Co-authors
- Lewis R. RobertsMinshan ChenMyron SchwartzPei‐Jer ChenPhilip J. JohnsonMorris ShermanMasatoshi KudoM. Colombo
- Cited by
- HepatologyNeurologyEpidemiology
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Lucinda Orsini
39 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Hepatology 809
- Neurology 233
- Epidemiology 514
- Oncology 388
- Cancer Research 196
Countries citing papers authored by Lucinda Orsini
This map shows the geographic impact of Lucinda Orsini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucinda Orsini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucinda Orsini more than expected).
Fields of papers citing papers by Lucinda Orsini
This network shows the impact of papers produced by Lucinda Orsini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucinda Orsini. The network helps show where Lucinda Orsini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lucinda Orsini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 15 | |
| 2 | 2021 | 13 | |
| 3 | 2020 | 87 | |
| 4 | 2020 | 19 | |
| 5 | 2017 | 9 | |
| 6 | 2017 | 79 | |
| 7 | 2016 | 58 | |
| 8 | 2016 | 1 | |
| 9 | 2015 | 4 | |
| 10 | 2015 | 5 | |
| 11 | 2015 | 6 | |
| 12 | 2013 | 4 | |
| 13 | 2011 | 19 | |
| 14 | 2011 | 102 | |
| 15 | 2007 | 4 | |
| 16 | 2005 | 38 | |
| 17 | 2004 | 103 | |
| 18 | 2004 | 89 | |
| 19 | 2004 | 47 | |
| 20 | 2004 | 12 |
About Lucinda Orsini
Lucinda Orsini is a scholar working on Hepatology, Family Practice and Statistics and Probability, having authored 39 papers that have together received 2.0k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Lung Cancer Treatments and Mutations (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Statistical Methods in Clinical Trials (4 papers), Advanced Causal Inference Techniques (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Hepatology (809 citations), Neurology (233 citations) and Epidemiology (514 citations). Lucinda Orsini has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Lewis R. Roberts, Minshan Chen, Myron Schwartz, Pei‐Jer Chen, Philip J. Johnson, Morris Sherman, Masatoshi Kudo, M. Colombo, Samuel Wagner and Joong‐Won Park. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.